SGHT News and Press, Sight Sciences Inc. From 07/19/21

Medical device maker Sight Sciences (SGHT) closed its IPO and raised about $276M in gross proceeds.The eye-disease focused company sold 11.5M common shares, including the exercise in full of the underwriters’ option to by 1.5 additional shares, at $24 each.The company's stock...

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases, today announced the ...

Sight Sciences has two innovative products to address eye diseases. Commercial traction is good, from a low sales base, as the potential is large. While the valuation is high, the potential is very large as well, making me interested in the name. For further details see: ...